Literature DB >> 11839582

Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.

Christophe Corpechot1, Veronique Barbu, Dominique Wendum, Nicolas Chignard, Chantal Housset, Raoul Poupon, Olivier Rosmorduc.   

Abstract

Hepatic resection in cirrhotic patients is associated with impaired liver regeneration and poor clinical outcome. Because experimental cirrhosis is associated with hepatic cell hypoxia, we herein investigated whether hypoxia might alter the mechanisms of liver regeneration in the cirrhotic liver. Cirrhosis was induced by diethylnitrosamine in rats. Immunohistochemistry was performed to assess hepatocellular hypoxia and proliferation 24 hours after a two-thirds partial hepatectomy (PH) in cirrhotic and control rats. Cultured hepatocytes and myofibroblastic hepatic stellate cells were submitted to hypoxia using anaerobic jars. Hepatocyte growth factor (HGF) and c-Met expressions were determined by reverse transcriptase-polymerase chain reaction, Northern blot, and Western blot. In control rats, hypoxia was restricted to perivenular hepatocytes, and PH induced a marked increase in hepatocyte proliferation and in liver HGF expression, whereas c-Met expression remained unchanged. In cirrhotic rats, hypoxia was detected virtually in all of the hepatocytes, and PH induced no significant change in hepatocyte proliferation and in liver HGF expression, whereas c-Met expression was decreased as compared to normal livers. In vitro, the expression of HGF in myofibroblastic hepatic stellate cells and of c-Met in hepatocytes underwent a dramatic decrease under hypoxia. Our results suggest that hepatocellular hypoxia causes inhibition of HGF (and of c-Met)-mediated proliferation and thereby might contribute to liver regeneration failure in cirrhotic liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839582      PMCID: PMC1850664          DOI: 10.1016/S0002-9440(10)64881-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Changes in growth factor and cytokine mRNA levels after hepatectomy in rat with CCl(4)-induced cirrhosis.

Authors:  S Masson; M Scotté; A François; M Coeffier; F Provot; M Hiron; P Ténière; J Fallu; J P Salier; M Daveau
Journal:  Am J Physiol       Date:  1999-10

2.  Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride.

Authors:  J J Maher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

3.  Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene.

Authors:  A Okajima; K Miyazawa; N Kitamura
Journal:  Eur J Biochem       Date:  1993-04-01

4.  Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro.

Authors:  K Matsumoto; H Fujii; G Michalopoulos; J J Fung; A J Demetris
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

5.  Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids.

Authors:  K Matsumoto; H Tajima; H Okazaki; T Nakamura
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

6.  Proliferating cell nuclear antigen, plasma fibronectin, and liver regeneration rate after seventy percent hepatectomy in normal and cirrhotic rats.

Authors:  K Chijiiwa; K Nakano; N Kameoka; E Nagai; M Tanaka
Journal:  Surgery       Date:  1994-09       Impact factor: 3.982

7.  Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration.

Authors:  K Matsumoto; H Okazaki; T Nakamura
Journal:  J Biochem       Date:  1995-02       Impact factor: 3.387

8.  Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.

Authors:  I R Wanless; F Wong; L M Blendis; P Greig; E J Heathcote; G Levy
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

9.  Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression.

Authors:  G Shiota; T C Wang; T Nakamura; E V Schmidt
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

10.  Hepatocyte growth factor up-regulates met expression in rat fetal hepatocytes in primary culture.

Authors:  C de Juan; A Sánchez; T Nakamura; I Fabregat; M Benito
Journal:  Biochem Biophys Res Commun       Date:  1994-11-15       Impact factor: 3.575

View more
  18 in total

1.  Diethylnitrosamine-induced cirrhosis in Wistar rats: an experimental feasibility study.

Authors:  Silvia Bona; Andrea Janz Moreira; Graziella Ramos Rodrigues; Carlos Thadeu Cerski; Themis Reverbel da Silveira; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2014-11-05       Impact factor: 3.356

Review 2.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

3.  Segmental cholangitis impairs hepatic regeneration capacity after partial hepatectomy in rats.

Authors:  Katsutaka Watanabe; Yukihiro Yokoyama; Toshio Kokuryo; Kiyotaka Kawai; Tomomi Kitagawa; Takashi Seki; Akifumi Nakagawa; Masato Nagino
Journal:  HPB (Oxford)       Date:  2010-11-08       Impact factor: 3.647

4.  Two cases of hepatopulmonary syndrome with improved liver function following long-term oxygen therapy.

Authors:  Kazuko Y Fukushima; Hiroshi Yatsuhashi; Akitoshi Kinoshita; Toshihito Ueki; Takehiro Matsumoto; Mitsuhiko Osumi; Yohjiro Matsuoka
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

5.  The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.

Authors:  Hyunsook Kang; Kang-Hyun Kim; Jisun Lim; You-Sun Kim; Jinbeom Heo; Jongjin Choi; Jaeho Jeong; YongHwan Kim; Seong Who Kim; Yeon-Mok Oh; Myung-Soo Choo; Jaekyoung Son; Su Jung Kim; Hyun Ju Yoo; Wonil Oh; Soo Jin Choi; Sei Won Lee; Dong-Myung Shin
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

6.  Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases.

Authors:  Claudia Paternostro; Ezio David; Erica Novo; Maurizio Parola
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

7.  Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure.

Authors:  Hee Joon Kim; Choong Young Kim; Eun Kyu Park; Young Hoe Hur; Yang Seok Koh; Hyun Jong Kim; Chol Kyoon Cho
Journal:  HPB (Oxford)       Date:  2014-06-25       Impact factor: 3.647

8.  Liver failure following partial hepatectomy.

Authors:  Thomas S Helling
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 9.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

10.  Influence of portosystemic shunt on liver regeneration after hepatic resection in pigs.

Authors:  R Ladurner; M Schenk; R Margreiter; F Offner; A Königsrainer
Journal:  HPB Surg       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.